Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 25, 2014. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on share repurchase activity and capital structure metrics:
- Shares Purchased: 114,000 Ordinary Shares on February 25, 2014.
- Price Range: Highest price paid was 1,680.50 pence per share; lowest price paid was 1,663.50 pence per share.
- Treasury Holdings (Settled): 488,755,669 shares, representing 9.14% of total issued share capital.
- Treasury Holdings (Including Unsettled): 488,929,169 shares, representing 10.06% of total voting rights.
- Shares in Issue (Excluding Treasury): 4,858,485,552 shares.
Material Changes
The material change reported is the reduction of outstanding shares through the purchase of 114,000 shares for treasury. Consequently, the percentage of total voting rights held in treasury increased to 10.06% when including unsettled purchases. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Points
- Verify the total number of shares held in treasury (488,929,169) against the company's latest capitalization table.
- Confirm the 10.06% voting rights threshold held in treasury for disclosure rule calculations.
- Note that this filing does not contain financial performance results; investors should refer to the most recent Form 20-F or quarterly earnings release for revenue and profit data.